Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Frontiers in Immunology|July 30, 2014
Extracellular adenosine-mediated modulation of regulatory T cellsAkio Ohta, Michail SitkovskyHandbook of Experimental Pharmacology|September 23, 2010
Methylxanthines, inflammation, and cancer: fundamental mechanismsAkio Ohta, Michail SitkovskyCurrent Opinion in Pharmacology|June 23, 2009
The adenosinergic immunomodulatory drugsAkio Ohta, Michail SitkovskyJournal of Molecular Medicine (Berlin, Germany)|January 22, 2013
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancerMichail Sitkovsky, Akio OhtaPurinergic Signalling|April 12, 2008
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapyDmitriy Lukashev, Michail Sitkovsky, Akio OhtaDrug Discovery Today|April 15, 2004
Targeting hypoxia--A(2A) adenosine receptor-mediated mechanisms of tissue protectionDmitriy Lukashev, Akio Ohta, Michail SitkovskyJournal of Leukocyte Biology|July 1, 2009
The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cellsStephen Hatfield, Bryan Belikoff, Dmitriy Lukashev, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2018
A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced ImmunosuppressionJorgen Kjaergaard, Stephen Hatfield, Graham Jones, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivoDmitriy Lukashev, Akio Ohta, Sergey Apasov, et al.Frontiers in Immunology|July 12, 2012
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathwayAkio Ohta, Radhika Kini, Akiko Ohta, et al.Pageof 14